Accurate Education - Nutraceutical Protocols: Complex Regional Pain Syndrome (CRPS)

Nutraceutical Protocols:

Complex Regional Pain Syndrome (CRPS)

CRPS is a chronic pain condition characterized by pain disproportionate to the inciting event, accompanied by sensory, autonomic, motor abnormalities.and atrophy. It typically develops after trauma such as fracture or surgery. [1][2]

See:

Nutraceutical Protocols:

Key to Links:

Grey text – handout
Red text – another page on this website
Blue text – Journal publication

Definitions and Terms Related to Pain

Nutraceutical Protocols:

Complex Regional Pain Syndrome (CRPS)

CRPS is characterized by pain disproportionate to the injury, associated with sensory, autonomic, motor abnormalities along with atrophy.[1][2] It typically develops after trauma with an incidence of 2–25% after wrist fracture and up to 13% after total knee arthroplasty.[1]

CRPS is now classified as nociplastic pain—pain arising from altered pain processing without clear evidence of tissue damage or somatosensory system lesion.[2] See Figure for distinction between Nociplastic vs Nocicptove vs Neuropathi Pain

CRPS condition often follows a biphasic course:

“Warm CRPS” (acute, inflammatory-dominant) transitioning to
“Cold CRPS” (chronic, central sensitization-dominant).[3][4]

Treatment

Currently, no FDA-approved treatments exist specifically for CRPS, and evidence for most interventions is limited.[5] based on the mechanisms responsible for CRPS pathology, certain nutraceuticals offer potential benefits for pain and other symptoms.

The 2024 Lancet Neurology review and 2025 NEJM review emphasize that CRPS pathophysiology involves aberrant inflammatory and immune responses, vasomotor dysfunction, and maladaptive neuroplasticity.[1][2] Emerging evidence supports an autoimmune mechanism, with IgG and IgM autoantibodies capable of transferring CRPS-like signs to animal models.[6]

Pathophysiology Targeted:

Neuroinflammation (substance P, CGRP release),
Aberrant immune/autoimmune response (autoantibodies, IL-1β, TNF-α, IL-6)
Oxidative stress/free radical production
Central Sensitization (with NMDA receptor upregulation)
Maladaptive neuroplasticity
Vasomotor dysfunction
Sympatho-afferent coupling
Mast cell activation
Microvascular dysfunction/tissue hypoxia

—

MECHANISTIC RATIONALE FOR NUTRACEUTICAL APPROACH

The pathophysiology of CRPS involves several mechanisms targetable by nutraceuticals:

1. Oxidative stress/free radical production: Elevated lipid peroxidation products (MDA) and compensatory antioxidant upregulation in CRPS patients. Free radical scavengers (DMSO, NAC) have shown efficacy in RCTs. Vitamin C, NAC, ALA address oxidative stress.[7][8]

2. Neurogenic inflammation: Elevated substance P, CGRP, bradykinin, and proinflammatory cytokines (TNF-α, IL-1β, IL-6). PEA, omega-3, curcumin reduce neurogenic inflammation.[1][9]

3. Central sensitization/NMDA receptor upregulation: Amplified neural signaling in spinal nociceptive neurons. Magnesium (NMDA antagonist) addresses central sensitization.[10][1][11]

4. Autoimmune/IL-1β-mediated mechanisms: IgG autoantibodies induce CRPS-like signs via IL-1β-mediated mechanisms; anakinra (IL-1R1 blockade) prevents and reverses these changes. Omega-3 and curcumin modulate immune responses.[6]

5. Microvascular dysfunction/tissue hypoxia: Local ischemia contributes to pain; NO-mediated tissue oxygenation is impaired. NAC (combined with meldonium) improves tissue oxygenation.[12]

6. Mast cell activation: Mast cell accumulation in affected skin. PEA modulates mast cell activity.[1]

—

NUTRACEUTICAL PROTOCOL FOR CRPS

IMPORTANT: No high-certainty evidence exists for any CRPS treatment[5]

The 2024 Lancet Neurology review notes that “extrapolation of data from other chronic pain conditions—such as neuropathic pain—is sometimes considered appropriate because of similarity of symptoms”[1]
Nutraceuticals should complement, not replace, the four pillars of CRPS care: education, pain relief, physical rehabilitation, and psychological intervention[1]

—

Tier 1: Prevention (Post-Trauma/Surgery)

Agent

Dosing Protocol

Evidence Level

Mechanism/Rationale

References

Vitamin C

500 mg–1000 mg daily

for 45–50 days post-injury

Meta-analyses positive; one negative RCT

Reduces oxidative stress;

meta-analysis showed 46% risk reduction;

2025 TKA study showed reduced CRPS incidence and recurrence

[1], [2], [3], [4], [5]

NAC

(N-Acetyl

Cysteine)

600 mg 3x/day

for prevention

One retrospective study positive

Reduced CRPS incidence

from 31% to 9.7% (78% reduction);

decreased IL-6, TNF-α, IL-1β; improved oxidative stress markers

[6]

[19][2][20][1][9][21][22] [23]

Vitamin C Evidence: A meta-analysis of 3 RCTs (875 patients with wrist fractures) found vitamin C 500 mg daily for 50 days reduced CRPS risk (RR 0.54, 95% CI 0.33–0.91, p=0.02).[2] A 2022 meta-analysis of 8 studies confirmed vitamin C was associated with decreased CRPS-I rates (OR 0.33, 95% CI 0.17–0.63).[21] However, the 2022 AAPM guideline notes a more recent large RCT found vitamin C was associated with increased CRPS incidence at 6 weeks, with no effect at subsequent time points, concluding “the potential utility of vitamin C in the prevention of CRPS therefore remains unproven.” A 2025 propensity-matched study of 960 TKAs found vitamin C prophylaxis (1 g daily for 40 days) reduced CRPS incidence (6.9% vs 11%, OR 0.59) and dramatically reduced recurrence in patients with prior CRPS (19% vs 71%, OR 0.09).[22][20]
NAC Prevention Evidence: A 2024 retrospective study found NAC 600 mg daily for 3 months reduced CRPS-I incidence from 31% to 9.7% (OR 0.22, p=0.032) in patients with distal radius fractures, with significant reductions in IL-6, TNF-α, IL-1β, and oxidative stress markers.[23]

—

Tier 2: Established CRPS – Acute/Warm Phase (<6 months)

Agent	Dosing Protocol	Evidence Level	Mechanism/Rationale	References
Vitamin C	500 mg–1 g daily	Supportive; primarily prevention data	Continues antioxidant support; reduces oxidative stress markers	[1], [2]
NAC	600 mg 3x/day (oral)	RCT positive for warm CRPS	Free radical scavenger; Dutch guideline recommends for inflammatory symptoms; RCT showed efficacy comparable to DMSO	[3], [4], [5]
PEA (Palmitoylethanolamide)	600 mg 2x/day (ultramicronized)	Preclinical positive in CRPS model	Reduced mast cell density, NGF, MMP-9, cytokines; Decreased peroxynitrite formation; Improved fracture healing in mouse CRPS model	[6]
Omega-3 (EPA/DHA)	2–3 gm daily	Preclinical positive	Preventive supplementation reduced pain and TNF-α, IL-1β in mouse CRPS-I model	[7]
Magnesium	400–600 mg daily	Systematic review: equivocal but promising	NMDA receptor antagonism; 2 RCTs in CRPS included in systematic review; addresses central sensitization	[8]

[19][2][20][1][9][21][22][23][8][26][4][12][7][27][25][28][11][29][9][21][30][8][29][31][27]

Free Radical Scavengers Evidence: The Dutch CRPS guidelines recommend free radical scavengers (DMSO or NAC) for inflammatory symptoms.[30] A landmark RCT (n=146) compared topical DMSO 50% vs oral NAC 600 mg TID for 17 weeks and found both equally effective overall, with DMSO more favorable for warm CRPS and NAC more effective for cold CRPS.[8]
PEA Evidence: A preclinical study using a tibia fracture mouse model of CRPS-I found micronized/ultramicronized PEA improved healing, reduced mast cell density, decreased NGF, MMP-9, and cytokine expression, and reduced peroxynitrite formation and apoptosis.[29]
Omega-3 Evidence: A 2022 preclinical study found 30-day preventive omega-3 supplementation reduced pain and proinflammatory cytokines (TNF-α, IL-1β) in a mouse CRPS-I model without affecting locomotion.[31]

—

Tier 3: Established CRPS – Chronic/Cold Phase (>6 months)

Agent	Dosing Protocol	Evidence Level	Mechanism/Rationale	References
NAC	600 mg 3x/day (oral)	RCT positive for cold CRPS	More effective than DMSO for cold CRPS in subgroup analysis; addresses oxidative stress	[1]
Magnesium	400–600 mg daily	Extrapolated from neuropathic pain	NMDA receptor antagonism; addresses central sensitization dominant in chronic phase	[2]
PEA	600 mg 2x/day (ultramicronized)	Extrapolated from neuropathic pain	Effective for nociplastic pain; reduces glial activation	[3]
Melatonin	5–10 mg at night	Extrapolated from neuropathic pain	Improves mitochondrial dysfunction; reduces neuroinflammation via SIRT1; addresses sleep disruption	[4]
Vitamin D3	Optimize to 40–60 ng/mL	Supportive care	Modulates opioid signaling; supports nerve function	[Document]

[19][2][20][1][9][21][22][23][8][26][4][12][7][27][25][28][11][29][8][27][11][25][28]

—

PHASE-BASED COMPREHENSIVE PROTOCOL

Phase 1: Prevention (Post-Trauma/Surgery)

Goal: Reduce oxidative stress and inflammation to prevent CRPS development

Vitamin C: 500 mg–1 g daily starting day of injury/surgery, continue for 45–50 days
Consider NAC: 600 mg daily for 3 months (especially for fractures)
Early mobilization and non-restrictive casting per guidelines[1]

Phase 2: Acute/Warm CRPS (<6 months)

Goal: Address inflammation, oxidative stress, neurogenic inflammation

Vitamin C: 500 mg–1 g daily (continue from prevention or initiate)
NAC: 600 mg TID (oral)
PEA (ultramicronized): 600 mg BID
Omega-3: 2–3 g EPA+DHA daily
Magnesium: 400 mg daily (glycinate or citrate)
Vitamin D3: Check 25(OH)D; optimize to 40–60 ng/mL

Phase 3: Chronic/Cold CRPS (>6 months)

Goal: Address central sensitization, neuroplasticity, ongoing oxidative stress

NAC: 600 mg TID (more effective for cold CRPS)
Magnesium: 400–600 mg daily (NMDA antagonism for central sensitization)
PEA: 600 mg BID (nociplastic pain)
Melatonin: 5–10 mg QHS (neuroinflammation, sleep, mitochondrial support)
Continue Vitamin D3 optimization
– Continue Omega-3: 2–3 g daily
– Consider Curcumin: 500 mg TID (anti-inflammatory, CaMKIIα inhibition per your document)
– Consider Resveratrol: 200–500 mg daily (SIRT1 activation, NMDA modulation per your document)

—

CRPS SUBTYPE-SPECIFIC CONSIDERATIONS

CRPS Subtype	Characteristics	Priority Nutraceuticals	Rationale	References
Warm CRPS	Acute; inflammatory; red, warm, limb edema	Vitamin C, DMSO (topical), PEA, Omega-3	Address inflammation and oxidative stress; DMSO more effective than NAC for warm CRPS	[1], [2]
Cold CRPS	Chronic; central sensitization; cold, cyanotic limb	NAC, Magnesium, Melatonin, Resveratrol	NAC more effective for cold CRPS; NMDA antagonism for central sensitization	[1], [2][3]
CRPS with motor symptoms	Dystonia, tremor, weakness	Magnesium, Melatonin	Central mechanisms; neuroplasticity	[4]
CRPS with spreading pain	Pain beyond initial site	Magnesium, PEA, Melatonin	Central sensitization; widespread sensitization	[5]

[19][2][20][1][9][21][22][23][8][26][4][12][7][27][25][28][11][29][10][32][33][8][4][8][11][10][10][4][1]

—

INTEGRATION WITH STANDARD CRPS THERAPY

The UK Royal College of Physicians guidelines recommend an integrated, multidisciplinary approach with four pillars of equal importance:[1]

Pillar	Standard Interventions	Nutraceutical Synergy	References
Education	Understanding CRPS; realistic expectations	Patient education on nutraceutical rationale	[1]
Pain Relief	NSAIDs, TCAs, SNRIs, gabapentinoids, bisphosphonates, corticosteroids	Vitamin C, NAC, PEA, Magnesium (complementary mechanisms)	[2], [3]
Physical Rehabilitation	PT/OT, graded motor imagery, mirror therapy	Magnesium (muscle function), PEA (pain reduction	[4]
Psychological Intervention	CBT, acceptance-based approaches	Melatonin (sleep, mood), Omega-3 (mood support)	[5]

[19][2][1][34][1][2][1][1][4][1]

Bisphosphonates: A meta-analysis of 10 trials (733 patients) found bisphosphonates associated with a 10-point improvement on a 100-point pain scale, with the most substantial effects in patients with recent-onset CRPS (<4 months).[2] Nutraceuticals can complement bisphosphonate therapy.
Corticosteroids: A short course of oral corticosteroids (e.g., methylprednisolone 100 mg tapered over 16 days) is commonly used for CRPS <6 months, though evidence is poor quality.[2] Nutraceuticals may provide ongoing anti-inflammatory support after steroid course.

—

MONITORING AND ASSESSMENT

Baseline Assessment:

– CRPS severity: Budapest criteria confirmation; pain intensity (VAS/NRS)

– Functional status: grip strength, range of motion, limb function

– CRPS features: temperature asymmetry, edema, color changes, motor symptoms

– Laboratory: 25(OH)D, inflammatory markers (CRP, ESR), oxidative stress markers if available

– Psychological assessment: anxiety, depression, catastrophizing

Follow-up (Monthly for first 3 months, then every 2–3 months):

– Pain scores and CRPS symptom assessment

– Functional status

– Response to rehabilitation

– Adverse effects

– Warm vs. cold CRPS classification (may change over time)

Expected Timeline:

Prevention: Vitamin C/NAC should be started immediately post-injury and continued for 45–50 days
Acute CRPS: Many cases resolve within the first year; nutraceuticals support this natural resolution[35]
Chronic CRPS: Improvement may be gradual; central sensitization requires sustained intervention

—

SPECIAL CONSIDERATIONS

Autoimmune Mechanisms: Emerging evidence supports autoantibody-mediated mechanisms in CRPS, with IL-1β playing a key role.[6] While anakinra (IL-1R1 blockade) has shown promise in preclinical models, nutraceuticals with anti-inflammatory effects (omega-3, curcumin, PEA) may provide complementary immune modulation.
Pediatric CRPS: Children with CRPS typically have better outcomes with multifaceted physical therapy.[32] Nutraceutical use in pediatric CRPS should be approached cautiously with age-appropriate dosing.

Drug Interactions:

– Vitamin C: Generally safe; high doses may affect certain lab tests
– NAC: May interact with nitroglycerin; generally well-tolerated
– Magnesium: May reduce absorption of certain antibiotics and bisphosphonates; separate dosing
– PEA: No significant drug interactions reported

Recurrent CRPS:

Patients with prior CRPS have a 5.4-fold increased risk of developing CRPS after subsequent surgery.[20] Vitamin C prophylaxis dramatically reduced recurrence (19% vs 71%) in one study.[20]

—

PATIENT EDUCATION HANDOUT

Managing Complex Regional Pain Syndrome: Your Supplement Guide

Understanding Complex Regional Pain Syndrome (CRPS)

Complex Regional Pain Syndrome is a chronic pain condition that usually develops after an injury, surgery, or fracture. It causes pain that is much more severe than expected from the original injury, along with changes in skin color, temperature, and swelling in the affected limb.

CRPS is a complex condition that involves:

– Inflammation and immune system changes

– Oxidative stress (damage from harmful molecules called free radicals)

– Changes in how your nervous system processes pain

– Changes in blood flow to the affected limb

—

Prevention After Injury or Surgery

If you’ve had a fracture or surgery, certain supplements may help reduce your risk of developing CRPS:

Vitamin C – 500 mg to 1 gram daily for 45–50 days

– Research suggests vitamin C may reduce CRPS risk by about 46%

– Works by reducing oxidative stress after injury

– Start the day of your injury or surgery

– Very safe with few side effects

—

Supplements That May Help Established CRPS

For Early/Warm CRPS (first 6 months, with redness, warmth, swelling):

N-Acetyl Cysteine (NAC) – 600 mg three times daily

– A powerful antioxidant that reduces harmful free radicals

– Has been studied specifically for CRPS

– May help reduce inflammation

PEA (Palmitoylethanolamide) – 600 mg twice daily

– A natural substance that reduces inflammation

– May help calm overactive immune cells

– Well-tolerated with few side effects

Omega-3 Fish Oil – 2–3 grams daily

– Reduces inflammation

– Supports healthy immune function

For Chronic/Cold CRPS (after 6 months, with cold, bluish limb):

NAC – 600 mg three times daily

– Research suggests NAC may work better for the “cold” type of CRPS

Magnesium – 400–600 mg daily

– Helps calm overactive pain signals in the nervous system

– May help with muscle tension and sleep

Melatonin – 5–10 mg at bedtime

– Helps with sleep, which is often disrupted in CRPS

– Has anti-inflammatory effects on the nervous system

—

Important Information

Supplements Are Part of a Comprehensive Approach

CRPS treatment works best when it includes:

– Physical and occupational therapy

– Medications prescribed by your doctor

– Psychological support

– Education about your condition

Supplements can support these treatments but should not replace them.

What to Expect

– CRPS often improves over time, especially with early treatment

– Supplements work gradually over weeks to months

– Keep track of your symptoms to see if supplements are helping

—

Safety Information

– Tell your healthcare team about all supplements you take

– Most of these supplements are well-tolerated

– NAC may cause mild stomach upset

– Magnesium may cause loose stools—start with a lower dose

– Vitamin C is very safe at recommended doses

When to Contact Your Healthcare Team:

– If your pain significantly worsens

– If you develop new symptoms

– If you experience any concerning side effects

—

Working With Your Healthcare Team

CRPS is best managed by a team that may include:

– Pain specialists

– Physical and occupational therapists

– Psychologists

– Your primary care doctor

Share this information with your healthcare team and work together to find the best approach for you. Many people with CRPS improve significantly with comprehensive treatment.

—

Clinical Implementation Notes

The evidence for nutraceuticals specifically in CRPS is limited but mechanistically rational. The 2024 Lancet Neurology review notes that “extrapolation of data from other chronic pain conditions—such as neuropathic pain—is sometimes considered appropriate because of similarity of symptoms.”[1]

Vitamin C has the most evidence for prevention, with meta-analyses showing risk reduction after fractures.[2][21] However, the 2022 AAPM guideline notes conflicting evidence from a more recent large RCT.[22] The 2025 TKA study provides strong support for vitamin C in preventing CRPS recurrence in high-risk patients.[20]

Free radical scavengers (NAC, DMSO) have direct RCT evidence in CRPS treatment.[8] The Dutch guidelines recommend these for inflammatory symptoms.[30] The subtype-specific findings (DMSO for warm CRPS, NAC for cold CRPS) provide important guidance for clinical use.

NAC for prevention is supported by a 2024 retrospective study showing 78% reduction in CRPS-I incidence with significant reductions in inflammatory and oxidative stress markers.[23]

PEA has strong preclinical evidence in a CRPS mouse model, showing reduced mast cell density, cytokines, and improved healing.[29] Its efficacy for nociplastic pain (SMD -0.59) in meta-analysis supports its use in CRPS, which is now classified as nociplastic pain.[25]

Magnesium addresses central sensitization through NMDA receptor antagonism, a key mechanism in chronic CRPS.[11][10] A systematic review included 2 RCTs in CRPS with equivocal but promising results.[27]

Key clinical recommendations:

1. Prevention is the strongest indication: Vitamin C (and possibly NAC) post-trauma/surgery

2. Subtype matters: DMSO for warm CRPS, NAC for cold CRPS

3. Multimodal approach: Nutraceuticals should complement the four pillars of CRPS care

4. Extrapolation is appropriate: Given limited CRPS-specific evidence, extrapolation from neuropathic pain literature is reasonable

5. Monitor for phase transition: Warm CRPS may transition to cold CRPS, requiring adjustment of nutraceutical approach

Would you like me to create a comprehensive summary document combining all twelve condition-specific protocols, or develop monitoring flowsheets and drug-nutraceutical interaction tables for clinical implementation?

References

Complex Regional Pain Syndrome: Advances in Epidemiology, Pathophysiology, Diagnosis, and Treatment. Ferraro MC, O’Connell NE, Sommer C, et al. The Lancet. Neurology. 2024;23(5):522-533. doi:10.1016/S1474-4422(24)00076-0.
Complex Regional Pain Syndrome. Goebel A. The New England Journal of Medicine. 2025;393(23):2338-2348. doi:10.1056/NEJMcp2415752.
Complex Regional Pain Syndrome-Significant Progress in Understanding. Birklein F, Schlereth T. Pain. 2015;156 Suppl 1:S94-S103. doi:10.1097/01.j.pain.0000460344.54470.20.
Complex Regional Pain Syndrome: An Optimistic Perspective. Birklein F, O’Neill D, Schlereth T. Neurology. 2015;84(1):89-96. doi:10.1212/WNL.0000000000001095.
Interventions for Treating Pain and Disability in Adults With Complex Regional Pain Syndrome- An Overview of Systematic Reviews. Ferraro MC, Cashin AG, Wand BM, et al. The Cochrane Database of Systematic Reviews. 2023;6:CD009416. doi:10.1002/14651858.CD009416.pub3.
Transfer of Complex Regional Pain Syndrome to Mice via Human Autoantibodies Is Mediated by Interleukin-1-Induced Mechanisms. Helyes Z, Tékus V, Szentes N, et al. Proceedings of the National Academy of Sciences of the United States of America. 2019;116(26):13067-13076. doi:10.1073/pnas.1820168116.
Serum and Salivary Oxidative Analysis in Complex Regional Pain Syndrome. Eisenberg E, Shtahl S, Geller R, et al. Pain. 2008;138(1):226-232. doi:10.1016/j.pain.2008.04.019.
The Treatment of Complex Regional Pain Syndrome Type I With Free Radical Scavengers: A Randomized Controlled Study. Perez MRSG, Zuurmond AWW, Bezemer DP, et al. Pain. 2003;102(3):297-307. doi:10.1016/S0304-3959(02)00414-1.
Oxidative Stress Contributes to Fracture/Cast-Induced Inflammation and Pain in a Rat Model of Complex Regional Pain Syndrome. Guo TZ, Wei T, Huang TT, Kingery WS, Clark JD. The Journal of Pain. 2018;19(10):1147-1156. doi:10.1016/j.jpain.2018.04.006.
Clinical Features and Pathophysiology of Complex Regional Pain Syndrome. Marinus J, Moseley GL, Birklein F, et al. The Lancet. Neurology. 2011;10(7):637-48. doi:10.1016/S1474-4422(11)70106-5.
Magnesium in Pain Research: State of the Art. Srebro D, Vuckovic S, Milovanovic A, et al. Current Medicinal Chemistry. 2017;24(4):424-434. doi:10.2174/0929867323666161213101744.
Topical Combination of Meldonium and N-Acetyl Cysteine Relieves Allodynia in Rat Models of CRPS-1 and Peripheral Neuropathic Pain by Enhancing NO-mediated Tissue Oxygenation. Fulas OA, Laferriere A, Stein RS, Bohle DS, Coderre TJ. Journal of Neurochemistry. 2020;152(5):570-584. doi:10.1111/jnc.14943.
Myofascial Pain Syndrome: An Update on Clinical Characteristics, Etiopathogenesis, Diagnosis, and Treatment. Steen JP, Jaiswal KS, Kumbhare D. Muscle & Nerve. 2025;71(5):889-910. doi:10.1002/mus.28377.
Myofascial Pain – A Major Player in Musculoskeletal Pain. Lam C, Francio VT, Gustafson K, et al. Best Practice & Research. Clinical Rheumatology. 2024;38(1):101944. doi:10.1016/j.berh.2024.101944.
Treatment and Management of Myofascial Pain Syndrome. Urits I, Charipova K, Gress K, et al. Best Practice & Research. Clinical Anaesthesiology. 2020;34(3):427-448. doi:10.1016/j.bpa.2020.08.003.
New Views of Myofascial Trigger Points: Etiology and Diagnosis. Simons DG. Archives of Physical Medicine and Rehabilitation. 2008;89(1):157-9. doi:10.1016/j.apmr.2007.11.016.
Acupotomy Alleviates Energy Crisis at Rat Myofascial Trigger Points. Zhang Y, Du NY, Chen C, et al. Evidence-Based Complementary and Alternative Medicine : eCAM. 2020;2020:5129562. doi:10.1155/2020/5129562.
Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective. Shah JP, Thaker N, Heimur J, et al. PM & R : The Journal of Injury, Function, and Rehabilitation. 2015;7(7):746-761. doi:10.1016/j.pmrj.2015.01.024.
The Role of Diet and Non-Pharmacologic Supplements in the Treatment of Chronic Neuropathic Pain: A Systematic Review. Frediani JK, Lal AA, Kim E, et al. Pain Practice : The Official Journal of World Institute of Pain. 2024;24(1):186-210. doi:10.1111/papr.13291.
Prophylaxis Against Complex Regional Pain Syndrome Recurrence With Vitamin C in Total Knee Arthroplasty: A Propensity Score-Matched Analysis of 960 Cases. Hernigou J, Chahidi E, Everaert J, et al. The Journal of Bone and Joint Surgery. American Volume. 2025;:00004623-990000000-01567. doi:10.2106/JBJS.24.01584.
Effect of Perioperative Vitamin C on the Incidence of Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis. Seth I, Bulloch G, Seth N, et al. The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons. 2022 Jul-Aug;61(4):748-754. doi:10.1053/j.jfas.2021.11.008.
Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition. Harden RN, McCabe CS, Goebel A, et al. Pain Medicine (Malden, Mass.). 2022;23(Suppl 1):S1-S53. doi:10.1093/pm/pnac046.
Efficacy of N-Acetylcysteine in Reducing Inflammation and Oxidative Stress to Prevent Complex Regional Pain Syndrome Type 1. Dinç M, Soydemir ÖC. Medicine. 2024;103(38):e39742. doi:10.1097/MD.0000000000039742.
Targeted Treatment of Age-Related Fibromyalgia With Supplemental Coenzyme Q10. Hargreaves IP, Mantle D. Advances in Experimental Medicine and Biology. 2021;1286:77-85. doi:10.1007/978-3-030-55035-6_5.
Meta-Analysis of Palmitoylethanolamide in Pain Management: Addressing Literature Gaps and Enhancing Understanding. Viña I, López-Moreno M. Nutrition Reviews. 2025;83(7):e1604-e1618. doi:10.1093/nutrit/nuae203.
Nrf2 Activation Mediates Antiallodynic Effect of Electroacupuncture on a Rat Model of Complex Regional Pain Syndrome Type-I Through Reducing Local Oxidative Stress and Inflammation. Li X, Yin C, Hu Q, et al. Oxidative Medicine and Cellular Longevity. 2022;2022:8035109. doi:10.1155/2022/8035109.
Efficacy and Safety of Magnesium for the Management of Chronic Pain in Adults: A Systematic Review. Park R, Ho AM, Pickering G, et al. Anesthesia and Analgesia. 2020;131(3):764-775. doi:10.1213/ANE.0000000000004673.
Melatonin Improves Mitochondrial Dysfunction and Attenuates Neuropathic Pain by Regulating SIRT1 in Dorsal Root Ganglions. Zeng Y, Fang Q, Chen J, et al. Neuroscience. 2023;534:29-40. doi:10.1016/j.neuroscience.2023.10.005.
Effect of a New Formulation of Micronized and Ultramicronized N-Palmitoylethanolamine in a Tibia Fracture Mouse Model of Complex Regional Pain Syndrome. Fusco R, Gugliandolo E, Campolo M, et al. PloS One. 2017;12(6):e0178553. doi:10.1371/journal.pone.0178553.
Evidence Based Guidelines for Complex Regional Pain Syndrome Type 1. Perez RS, Zollinger PE, Dijkstra PU, et al. BMC Neurology. 2010;10:20. doi:10.1186/1471-2377-10-20.
Preventive Supplementation of Omega-3 Reduces Pain and Pro-Inflammatory Cytokines in a Mouse Model of Complex Regional Pain Syndrome Type I. de Oliveira Galassi T, Fernandes PF, Salgado ASI, et al. Frontiers in Integrative Neuroscience. 2022;16:840249. doi:10.3389/fnint.2022.840249.
Complex Regional Pain Syndrome: Evidence-Based Advances in Concepts and Treatments. Limerick G, Christo DK, Tram J, et al. Current Pain and Headache Reports. 2023;27(9):269-298. doi:10.1007/s11916-023-01130-5.
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome. Mangnus TJP, Bharwani KD, Dirckx M, Huygen FJPM. Drugs. 2022;82(5):511-531. doi:10.1007/s40265-022-01685-4.
Complex Regional Pain Syndrome. Lloyd ECO, Dempsey B, Romero L. American Family Physician. 2021;104(1):49-55.
Complex Regional Pain Syndrome. Bruehl S. BMJ (Clinical Research Ed.). 2015;351:h2730. doi:10.1136/bmj.h2730.

Emphasis on Education

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

For more information, please contact Accurate Clinic.

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.